4//SEC Filing
Shtylla Brunilda 4
Accession 0001209191-23-047512
CIK 0001382101other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:18 PM ET
Size
5.2 KB
Accession
0001209191-23-047512
Insider Transaction Report
Form 4
Shtylla Brunilda
Chief Business Officer
Transactions
- Sale
Common Stock
2023-08-25$4.59/sh−11,613$53,282→ 12,928 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.58 to $4.615, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001966915
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:18 PM ET
- Size
- 5.2 KB